Negri Donatella R M, Michelini Zuleika, Baroncelli Silvia, Spada Massimo, Vendetti Silvia, Bona Roberta, Leone Pasqualina, Klotman Mary E, Cara Andrea
Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
J Biomed Biotechnol. 2010;2010:534501. doi: 10.1155/2010/534501. Epub 2010 May 19.
CD8+ T cells are an essential component of an effective host immune response to tumors and viral infections. Genetic immunization is particularly suitable for inducing CTL responses, because the encoded proteins enter the MHC class I processing pathway through either transgene expression or cross-presentation. In order to compare the efficiency and persistence of immune response induced by genetic vaccines, BALB/c mice were immunized either twice intramuscularly with DNA plasmid expressing a codon-optimized HIV-1 gp120 Envelope sequence together with murine GM-CSF sequence or with a single immunization using an integrase defective lentiviral vector (IDLV) expressing the same proteins. Results strongly indicated that the schedule based on IDLV vaccine was more efficient in inducing specific immune response, as evaluated three months after the last immunization by IFNgamma ELISPOT in both splenocytes and bone marrow- (BM-) derived cells, chromium release assay in splenocytes, and antibody detection in sera. In addition, IDLV immunization induced high frequency of polyfunctional CD8+ T cells able to simultaneously produce IFNgamma, TNFalpha, and IL2.
CD8 + T细胞是宿主对肿瘤和病毒感染产生有效免疫反应的重要组成部分。基因免疫特别适合诱导细胞毒性T淋巴细胞(CTL)反应,因为编码的蛋白质通过转基因表达或交叉呈递进入MHC I类加工途径。为了比较基因疫苗诱导的免疫反应的效率和持久性,用表达密码子优化的HIV-1 gp120包膜序列和小鼠GM-CSF序列的DNA质粒对BALB/c小鼠进行两次肌肉注射免疫,或者用表达相同蛋白质的整合酶缺陷型慢病毒载体(IDLV)进行单次免疫。结果强烈表明,基于IDLV疫苗的免疫方案在诱导特异性免疫反应方面更有效,在最后一次免疫三个月后,通过对脾细胞和骨髓(BM)来源细胞进行IFNγ ELISPOT检测、对脾细胞进行铬释放试验以及对血清进行抗体检测来评估。此外,IDLV免疫诱导了能够同时产生IFNγ、TNFα和IL2的多功能CD8 + T细胞的高频率产生。